• News

  • September 15, 2014 ---      Meet ugichem at the BIO-Europe 2014 in Frankfurt (Nov. 3-5, 2014)

    September 3, 2014 ---       ugichem to present at the BIOTECH IN EUROPE FORUM For Global Partnering & Investment in Basel (Sept. 30-Oct. 1, 2014)

    June 4, 2014 ---                  ugichem to present at the Nucleic Acid Summit 2014 in San Diego (June 19-20, 2014)

     

     

     

     

     

  • Welcome!

  • ugichem is developing next generation antisense drugs, called Ugimers. The “Ugimer toolkit” allows an unattainable customization of cell and organ specificity for antisense drugs to target previously inaccessible clinical pathways.

    Ugimers allow overcoming the shortcomings of standard antisense chemistries or RNAi since they are not derived from natural nucleic acids. Ugimers are based on the PNA backbone and carry specific side chains enabling an organ and cell specific antisense drug development. As one result of this, Ugimers have an improved therapeutic window especially for immune cell mediated disorders such as inflammatory/autoimmune diseases, cancer and degenerative diseases.